Business Wire

In Celebration of World Rainforest Day, 33 Qualified Teams and 9 Judges Announced in $10M XPRIZE Competition to Improve Understandings and Preservation of the Planet’s Rainforests

Share

XPRIZE, the global leader in designing and operating incentive competitions to solve humanity’s grand challenges, officially announced today the teams moving forward in the $10M XPRIZE Rainforest aimed at improving our understanding of the rainforest ecosystem.

Sponsored by Alana Foundation, the five-year XPRIZE Rainforest is a call-to-action to help save rainforests through the development of transformative, scalable, and affordable technology to autonomously survey and monitor biodiversity in real-time, leading to insights that communicate the health, well-being, and value of standing tropical rainforests. XPRIZE Rainforest is co-developing an inclusive framework throughout all stages of the competition that ensures competing teams co-design and co-create solutions with Indigenous Peoples and local communities as key stakeholders and not just beneficiaries.

These 33 teams will now leverage existing and emerging technologies, such as robotics, remote sensing, data analysis, artificial intelligence, and machine learning, to develop new rainforest biodiversity survey tools that deliver information more quickly and affordably, and in unprecedented detail.

“There has never been a more urgent time for our planet,” Peter Houlihan, Vice President of Biodiversity & Conservation at XPRIZE said. “These teams show great promise for developing exciting new approaches to enhance shared understandings of the planet’s most complex and biodiverse terrestrial ecosystems.”

All registered teams submitted a qualifying submission detailing their approach and proposed technologies. The judging panel selected 33 teams, which hail from more than 16 countries and bring a collection of diverse backgrounds and industry experience.

The XPRIZE Rainforest qualified teams are:

  • ACT NOW - Amazonas Action Alliance, Ecuador
  • AirWrx, Canada
  • Alouatta, Mexico
  • AraceEye, Canada
  • BiodivExplorer, Switzerland
  • BioSTREAM, United Kingdom
  • Bioverse, Brazil
  • Blue Devil Rainforest Divers, United States
  • Brazilian Team, Brazil
  • Dinizia Excelsa, Brazil
  • FLOATING FAB, Peru
  • GainForest, Switzerland
  • Inspire Robotics, United States
  • KAA Initiative, Brazil
  • Kreativno pero, Serbia
  • Lorax, United States
  • Map of Life, United States
  • Mimicry Maniacs, United States
  • Mowgli, India
  • Nga Kaitiaki o te Ngaherehere, New Zealand
  • PROVIDENCE PLUS, Spain
  • Rainforest Quest, United States
  • Reforester, Netherlands
  • Selvascope, Netherlands
  • Short-Eared Dogs, United States
  • Team Morpho, United States
  • Team Robotics, Japan
  • Team Waponi!, United States
  • Tengo Research Foundation, Panama
  • Treeswift (Trefos Inc), United States
  • Welcome to the Jungle, United States
  • XiniX AI, Belgium
  • Zissou, Brazil

Additional details about all competing teams can be found here. Additionally, watch Peter Houlihan speak about XPRIZE Rainforest, performanced-based design and goal setting for impact on a World Rainforest Day event as part of the Rainforest Ambitions series. Register here.

In order to win the competition, the winning team will survey the most biodiversity contained in 100 hectares of tropical rainforest in 24 hours and produce the most impactful real time insights within 48 hours.

“Nature Based Solutions are key to confronting the climate crises. We are celebrating teams from the Americas, Europe, Oceania, and Asia all united on the same goal: protecting our standing forests that provide water, biodiversity, livelihood, and our prosperity with an inclusive bioeconomy. The joining of these teams shows the urgency we have to change the scenario we are living. The world needs intelligent, possible, powerful solutions, but above all, made by people in communion. We hope that Alana Rainforest XPRIZE will inspire activism, science, and innovation for the benefit of the environment and people all over the world,” said Ana Lúcia Villela, president of Alana Foundation.

Successful technologies developed in the competition will demonstrate scalable and affordable capabilities that measurably improve biodiversity monitoring, including through better autonomous operations, innovative detection methodologies, and rapid data integration to provide new Insights in real time and at unprecedented levels of detail.

The XPRIZE Rainforest Judging Panel consists of an experienced and talented group of experts working at the highest levels of academia, leading conservation organizations, prestigious research institutions and grantmaking organizations. The 9 judges include:

  • Dr. Jorge Ahumada –– Senior Wildlife Conservation Scientist, Conservation International
  • Dr. Luisa Arnedo –– Primatologist, Conservationist, and Senior Program Officer, National Geographic Society
  • Dr. Stuart Davies –– ​​​Director, Center for Tropical Forest Science-Forest Global Earth Observatory at the Smithsonian Institution
  • Dr. Lian Pin Koh –– Professor of Conservation, Science, Technology & Policy, Founder, Conservation Drones
  • Dr. Lucia Lohmann –– Executive Director, Association for Tropical Biology and Conservation
  • Dr. Kevin Njabo –– Associate Director & Africa Director, UCLA Center for Tropical Research and the Congo Basin Institute
  • Dr. Vojtech Novotny –– Head, Dep. of Ecology, Biology Centre, Czech Academy of Sciences Director, New Guinea Binatang Research Center, Professor of Ecology, Zoology Dep., University of South Bohemia
  • Atossa Soltani –– Founder & President of the Board, Amazon Watch; Director of Global Strategy for Amazon Sacred Headwaters Initiative
  • Dr. Dave Thau –– Lead Scientist, World Wildlife Fund Global Data and Tech

The next step for the competition is the semifinal round and then a final round of testing before the grand prize decision in 2024. A total prize purse of $10 Million US dollars (USD) will be awarded throughout the lifespan of the prize, including a $250,0000 Bonus Prize that may be awarded at the Judging Panel’s discretion to one or more Finalist Teams whose Solutions demonstrate groundbreaking achievements. Milestone prizes will also be awarded equally for up to 25 teams that advance to Semifinals and up to 10 teams that advance to finals testing.

ABOUT XPRIZE

XPRIZE, a 501(c)(3) nonprofit organization, is the global leader in designing and implementing innovative competition models to solve the world’s grandest challenges. Active competitions include the $100M XPRIZE Carbon Removal, $15M XPRIZE Feed the Next Billion, $10 Million ANA Avatar XPRIZE and $5 Million XPRIZE Rapid Reskilling. For more information, visit xprize.org.

ABOUT ALANA FOUNDATION

Alana Foundation is an independent philanthropic organisation founded in 2012 in the United States. The Foundation supports initiatives in the areas of environment, inclusive education and health science research through grants and co-funding partnerships. It also engages with networks and global movements in those areas.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Caden Kinard, XPRIZE
caden.kinard@xprize.org

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 18:22:00 EEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/ Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 15:30:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 15:00:00 EEST | Press release

The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye